• Return to Headlines

Lowest Return on Equity in the Pharmaceuticals Industry Detected in Shares of Neos Therapeutic (NEOS, NKTR, MDCO, TBPH, ENDP)

By Shiri Gupta

Below are the three companies in the Pharmaceuticals industry with the lowest return on equity. The ROE is a general indication of the company's efficiency; investors usually look for companies with ROEs that are high and are growing.

Neos Therapeutic ranks lowest with a ROE of -46,013.5%. Nektar Therapeut is next with a ROE of -24,966.6%. Medicines Comp ranks third lowest with a ROE of -17,771.8%.

Theravance B follows with a ROE of -15,960.3%, and Endo Internation rounds out the bottom five with a ROE of -12,775.8%.

SmarTrend recommended that its subscribers protect gains by selling shares of Theravance B on February 26th, 2019 by issuing a Downtrend alert when the shares were trading at $24.27. Since that call, shares of Theravance B have fallen 5.4%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: lowest return on equity neos therapeutic nektar therapeut medicines comp theravance b :endp endo internation

Ticker(s): NEOS NKTR MDCO TBPH